BlackRock (BLK) Replacing Genzyme (GENZ) in S&P 500
Tweet
Share
E-mail
Get Alerts BLK Hot Sheet
Price: $749.98 +0.36%
Overall Analyst Rating:
BUY (
Down)
Dividend Yield: 2.7%
Revenue Growth %: +11.6%
Overall Analyst Rating:
BUY (
Down)Dividend Yield: 2.7%
Revenue Growth %: +11.6%
Join SI Premium – FREE
BlackRock Inc. (NYSE: BLK) will replace Genzyme Corp. (NASDAQ: GENZ) in the S&P 500 index after the close of trading on Friday, April 1, 2011. S&P Global 1200 constituent Sanofi-aventis (NYSE: SNY) is acquiring Genzyme in a deal expected to be completed soon, pending final conditions.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Lululemon Athletica Inc. (LULU) PT Lowered to $505 at Baird
- Super Micro Computer (SMCI) Falls 6%
Create E-mail Alert Related Categories
Corporate News, Trader TalkRelated Entities
Standard & Poor's, Genzyme/Sanofi-AventisSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
